| 1 |
|
Signaling by Erythropoietin
|
40 |
0.439 |
|
|
| 2 |
|
Gene expression (Transcription)
|
1546 |
0.439 |
|
|
| 3 |
|
Angiopoietin-like protein 8 regulatory pathway
|
194 |
0.439 |
|
|
| 4 |
|
IL2 signaling events mediated by STAT5
|
74 |
0.439 |
|
|
| 5 |
|
Signaling by CSF3 (G-CSF)
|
30 |
0.439 |
|
|
| 6 |
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
52 |
0.439 |
|
|
| 7 |
|
NF-kappaB Signaling
|
327 |
0.439 |
|
|
| 8 |
|
IL-10 Pathway
|
35 |
0.439 |
|
|
| 9 |
|
Leptin-insulin signaling overlap
|
21 |
0.439 |
|
|
| 10 |
|
Immune response_IL-6 signaling pathway
|
33 |
0.439 |
|
|
| 11 |
|
IL4-mediated signaling events
|
60 |
0.439 |
|
|
| 12 |
|
Nonalcoholic fatty liver disease
|
46 |
0.439 |
|
|
| 13 |
|
JAK-STAT signaling in the regulation of Beta-cells
|
35 |
0.439 |
|
|
| 14 |
|
MIF Mediated Glucocorticoid Regulation
|
681 |
0.439 |
|
|
| 15 |
|
Adipogenesis
|
131 |
0.439 |
|
|
| 16 |
|
Immune response IL-2 activation and signaling pathway
|
75 |
0.439 |
|
|
| 17 |
|
Neuroinflammation and glutamatergic signaling
|
140 |
0.439 |
|
|
| 18 |
|
Interleukin-11 signaling pathway
|
44 |
0.439 |
|
|
| 19 |
|
Immune response IL-23 signaling pathway
|
160 |
0.439 |
|
|
| 20 |
|
Growth hormone receptor signaling
|
29 |
0.439 |
|
|
| 21 |
|
Prolactin Signaling
|
432 |
0.439 |
|
|
| 22 |
|
Host-pathogen interaction of human coronaviruses - interferon induction
|
52 |
0.439 |
|
|
| 23 |
|
Interleukin-6 family signaling
|
33 |
0.439 |
|
|
| 24 |
|
TGF-Beta Pathway
|
653 |
0.439 |
|
|
| 25 |
|
Overview of interferons-mediated signaling pathway
|
168 |
0.439 |
|
|
| 26 |
|
IL 10 signaling pathway
|
62 |
0.439 |
|
|
| 27 |
|
Immune response_IL-12 signaling pathway
|
25 |
0.439 |
|
|
| 28 |
|
Metabolism of proteins
|
1970 |
0.439 |
|
|
| 29 |
|
Development EPO-induced Jak-STAT pathway
|
75 |
0.439 |
|
|
| 30 |
|
Tyrosine Kinases / Adaptors
|
148 |
0.439 |
|
|
| 31 |
|
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
|
8 |
0.439 |
|
|
| 32 |
|
Cytokine Signaling in Immune system
|
732 |
0.439 |
|
|
| 33 |
|
Type II interferon signaling
|
37 |
0.439 |
|
|
| 34 |
|
Regulatory circuits of the STAT3 signaling pathway
|
24 |
0.439 |
|
|
| 35 |
|
IL-9 Signaling Pathways
|
169 |
0.439 |
|
|
| 36 |
|
Interleukin-4 and Interleukin-13 signaling
|
108 |
0.439 |
|
|
| 37 |
|
Ebola virus infection in host
|
129 |
0.439 |
|
|
| 38 |
|
Signaling events mediated by PTP1B
|
46 |
0.439 |
|
|
| 39 |
|
Jak-Stat Signaling Pathway
|
88 |
0.439 |
|
|
| 40 |
|
ATF-2 transcription factor network
|
57 |
0.439 |
|
|
| 41 |
|
Th17 cell differentiation pathway
|
69 |
0.439 |
|
|
| 42 |
|
IL6-mediated signaling events
|
45 |
0.439 |
|
|
| 43 |
|
IL-26 signaling pathways
|
35 |
0.439 |
|
|
| 44 |
|
Signal Transduction
|
2590 |
0.439 |
|
|
| 45 |
|
Immune response Antigen presentation by MHC class II
|
99 |
0.439 |
|
|
| 46 |
|
Signaling by PTK6
|
54 |
0.439 |
|
|
| 47 |
|
Class I MHC mediated antigen processing and presentation
|
855 |
0.439 |
|
|
| 48 |
|
Development_Leptin signaling via JAK/STAT and MAPK cascades
|
28 |
0.439 |
|
|
| 49 |
|
Translation Insulin regulation of translation
|
183 |
0.439 |
|
|
| 50 |
|
Mammary gland development pathway - Involution (Stage 4 of 4)
|
10 |
0.439 |
|
|
| 51 |
|
Innate Immune System
|
2025 |
0.439 |
|
|
| 52 |
|
Assembly of the pre-replicative complex
|
316 |
0.439 |
|
|
| 53 |
|
Development_Thrombopoetin signaling via JAK-STAT pathway
|
23 |
0.439 |
|
|
| 54 |
|
Interferon gamma signaling
|
203 |
0.439 |
|
|
